Plasma Therapies

HA330

Haemoperfusion Cartridge

Product Description

The HA330 is a Haemoperfusion cartridge that can be used as a stand alone device or in conjunction with other other extra-corporeal therapies.

The HA330 has the ability to remove pro-inflammatory cytokines and other cellular inflammatory markers found in “cytokine storm”.

Clinical Indications Include:

  • Patients unresponsive to vasopressor support
  • Patients unresponsive to standard of care who have multiple organ failure
  • Patients exhibiting signs of Damage Associated Molecular Patterns (DAMPS) or Pathogen Associated Molecular Patterns (PAMPS)
  • Patients on ECMO
  • Intra-operative cardiac surgery where the patient already has significant pre-existing cellular inflammatory activation such as Heart Failure where a LVAD device is to be implanted
  • Patients requiring long pump procedures such as Heart / Lung transplant or other procedures.

Request a free demonstration

Using the Jafron Adsorber in COVID-19 Patients
HA330 Disposable Hemoperfusion Cartridge
HA330

Indication

Improves organ functions

Clears excessive inflammatory mediators

Technical Details:

Product parameter   HA330
  Loading capacity (ml)   330±3
  Volumn (ml)   185±5
  Absorbent material   Styrene divinybenzene copolymers
  Housing material   Polycarbonate
  Sterilization method   Irradiation sterilization
  Unit package   290mm(L)×105mm(W)×105mm(H) 0.90kg
  • COVID-19: The use of Jafron Adsorber in severely ill patients

  • Topic Exploration Report

Related Products
Interested in this product?

Request a call-back